Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.
Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Scientists have uncovered an enormous hidden archive of plant DNA that has endured for more than 400 million years. By comparing hundreds of plant genomes, researchers identified more than 2.3 million ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
Testing Market size is USD 2.24 Billion in 2025 and is expected to reach USD 6.66 Billion by 2035 due to the increasing adoption of NIPTAustin, March 10, 2026 (GLOBE NEWSWIRE) -- According to SNS ...
Podar and colleagues created synthetic nanobodies for the radiopharmaceutical project by inserting synthetic genes into E. coli bacteria, fine-tuning conditions like temperature and adding sequence ...
Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently ...
A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results